サマリー

市場の分析と洞察。A型肝炎ワクチンの世界市場
COVID-19の大流行により、A型肝炎ワクチンの世界市場規模は2022年に7億3586万米ドルと推定され、レビュー期間中にCAGR2.24％で2028年までに8億4042万米ドルに再調整されると予測されています。
A型肝炎ワクチンの世界的な主要メーカーは、GSK、Merck、Sanofi、Sinovac、Zhejiang Pukang、Changchun Institute of Biological、KM Biologics、IMBCAMS、AIM Vaccineなどです。2021年、世界の上位5社の売上高シェアは約81.09％です。
世界のA型肝炎ワクチンの範囲とセグメント
A型肝炎ワクチン市場は、タイプ別、用途別に分類されています。A型肝炎ワクチンの世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てます。

会社別
GSK
メルク
サノフィ
シノバック
浙江省普康市
長春生物学研究所
KMバイオロジックス
IMBCAMS
AIMワクチン

種類別セグメント
不活性化ワクチン
弱毒生ワクチン

用途別セグメント
政府機関
民間企業
その他

地域別セグメント
北米
米国
カナダ
メキシコ

アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
東南アジア

ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア

南米
ブラジル

中東・アフリカ
中東
アフリカ

ページTOPに戻る

目次

1 STUDY COVERAGE 1
1.1 Hepatitis A Vaccine Product Introduction 1
1.2 Market by Type 2
1.2.1 Global Hepatitis A Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 2
1.2.2 Inactivated Vaccine 4
1.2.3 Live Attenuated Vaccine 5
1.3 Market by Application 5
1.4 Study Objectives 7
1.5 Years Considered 8
2 EXECUTIVE SUMMARY 9
2.1 Global Hepatitis A Vaccine Sales Estimates and Forecasts 2017-2028 9
2.2 Global Hepatitis A Vaccine Revenue Estimates and Forecasts 2017-2028 10
2.3 Global Hepatitis A Vaccine Revenue by Region: 2017 VS 2021 VS 2028 11
2.4 Global Hepatitis A Vaccine Sales by Region 13
2.4.1 Global Hepatitis A Vaccine Sales by Region (2017-2022) 13
2.4.2 Global Sales Hepatitis A Vaccine by Region (2023-2028) 14
2.5 Global Hepatitis A Vaccine Revenue by Region 15
2.5.1 Global Hepatitis A Vaccine Revenue by Region (2017-2022) 15
2.5.2 Global Hepatitis A Vaccine Revenue by Region (2023-2028) 16
2.6 North America 17
2.7 Europe 18
2.8 Asia-Pacific 19
2.9 South America 20
2.10 Middle East & Africa 21
3 COMPETITION BY MANUFACTURERS 23
3.1 Global Hepatitis A Vaccine Sales by Manufacturers 23
3.1.1 Global Hepatitis A Vaccine Sales by Manufacturers (2020-2022) 23
3.1.2 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2020-2022) 24
3.1.3 Global Top Largest Manufacturers of Hepatitis A Vaccine in 2021 24
3.2 Global Hepatitis A Vaccine Revenue by Manufacturers 25
3.2.1 Global Hepatitis A Vaccine Revenue by Manufacturers (2020-2022) 25
3.2.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2020-2022) 26
3.2.3 Global Top Companies by Hepatitis A Vaccine Revenue in 2021 26
3.3 Global Hepatitis A Vaccine Sales Price by Manufacturers (2020-2022) 27
3.4 Analysis of Competitive Landscape 28
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 28
3.4.2 Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) 29
3.4.3 Global Hepatitis A Vaccine Manufacturers Geographical Distribution 29
3.5 Mergers & Acquisitions, Expansion Plans 31
4 MARKET SIZE BY TYPE 33
4.1 Global Hepatitis A Vaccine Sales by Type 33
4.1.1 Global Hepatitis A Vaccine Historical Sales by Type (2017-2022) 33
4.1.2 Global Hepatitis A Vaccine Forecasted Sales by Type (2023-2028) 33
4.1.3 Global Hepatitis A Vaccine Sales Market Share by Type (2017-2028) 33
4.2 Global Hepatitis A Vaccine Revenue by Type 34
4.2.1 Global Hepatitis A Vaccine Historical Revenue by Type (2017-2022) 34
4.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Type (2023-2028) 35
4.2.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2017-2028) 35
4.3 Global Hepatitis A Vaccine Price by Type 36
4.3.1 Global Hepatitis A Vaccine Price by Type (2017-2022) 36
4.3.2 Global Hepatitis A Vaccine Price Forecast by Type (2023-2028) 36
5 MARKET SIZE BY APPLICATION 37
5.1 Global Hepatitis A Vaccine Sales by Application 37
5.1.1 Global Hepatitis A Vaccine Historical Sales by Application (2017-2022) 37
5.1.2 Global Hepatitis A Vaccine Forecasted Sales by Application (2023-2028) 37
5.1.3 Global Hepatitis A Vaccine Sales Market Share by Application (2017-2028) 37
5.2 Global Hepatitis A Vaccine Revenue by Application 38
5.2.1 Global Hepatitis A Vaccine Historical Revenue by Application (2017-2022) 38
5.2.2 Global Hepatitis A Vaccine Forecasted Revenue by Application (2023-2028) 39
5.2.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2017-2028) 39
5.3 Global Hepatitis A Vaccine Price by Application 40
5.3.1 Global Hepatitis A Vaccine Price by Application (2017-2022) 40
5.3.2 Global Hepatitis A Vaccine Price Forecast by Application (2023-2028) 41
6 NORTH AMERICA 42
6.1 North America Hepatitis A Vaccine Market Size by Type 42
6.1.1 North America Hepatitis A Vaccine Sales by Type (2017-2028) 42
6.1.2 North America Hepatitis A Vaccine Revenue by Type (2017-2028) 43
6.2 North America Hepatitis A Vaccine Market Size by Application 44
6.3 North America Hepatitis A Vaccine Sales by Country 45
6.3.1 North America Hepatitis A Vaccine Sales by Country (2017-2028) 45
6.3.2 North America Hepatitis A Vaccine Revenue by Country (2017-2028) 46
6.3.3 U.S. 47
6.3.4 Canada 47
6.3.5 Mexico 48
7 EUROPE 49
7.1 Europe Hepatitis A Vaccine Market Size by Type 49
7.1.1 Europe Hepatitis A Vaccine Sales by Type (2017-2028) 49
7.1.2 Europe Hepatitis A Vaccine Revenue by Type (2017-2028) 50
7.2 Europe Hepatitis A Vaccine Market Size by Application 51
7.3 Europe Hepatitis A Vaccine Market Size by Country 52
7.3.1 Europe Hepatitis A Vaccine Sales by Country (2017-2028) 52
7.3.2 Europe Hepatitis A Vaccine Revenue by Country (2017-2028) 53
7.3.3 Germany 55
7.3.4 France 55
7.3.5 U.K. 56
7.3.6 Italy 56
7.3.7 Russia 57
8 ASIA PACIFIC 58
8.1 Asia Pacific Hepatitis A Vaccine Market Size by Type 58
8.1.1 Asia Pacific Hepatitis A Vaccine Sales by Type (2017-2028) 58
8.1.2 Asia Pacific Hepatitis A Vaccine Revenue by Type (2017-2028) 59
8.2 Asia Pacific Hepatitis A Vaccine Market Size by Application 60
8.3 Asia Pacific Hepatitis A Vaccine Market Size by Region 61
8.3.1 Asia Pacific Hepatitis A Vaccine Sales by Region (2017-2028) 61
8.3.2 Asia Pacific Hepatitis A Vaccine Revenue by Region (2017-2028) 62
8.3.3 China 64
8.3.4 Japan 64
8.3.5 South Korea 65
8.3.6 India 65
8.3.7 Australia 66
8.3.8 Southeast Asia 66
9 SOUTH AMERICA 67
9.1 South America Hepatitis A Vaccine Market Size by Type 67
9.1.1 South America Hepatitis A Vaccine Sales by Type (2017-2028) 67
9.1.2 South America Hepatitis A Vaccine Revenue by Type (2017-2028) 68
9.2 South America Hepatitis A Vaccine Market Size by Application 69
9.3 South America Hepatitis A Vaccine Market Size by Country 70
9.3.1 South America Hepatitis A Vaccine Sales by Country (2017-2028) 70
9.3.2 South America Hepatitis A Vaccine Revenue by Country (2017-2028) 71
9.3.3 Brazil 72
10 MIDDLE EAST AND AFRICA 73
10.1 Middle East and Africa Hepatitis A Vaccine Market Size by Type 73
10.1.1 Middle East and Africa Hepatitis A Vaccine Sales by Type (2017-2028) 73
10.1.2 Middle East and Africa Hepatitis A Vaccine Revenue by Type (2017-2028) 74
10.2 Middle East and Africa Hepatitis A Vaccine Market Size by Application 75
10.3 Middle East and Africa Hepatitis A Vaccine Market Size by Country 76
10.3.1 Middle East and Africa Hepatitis A Vaccine Sales by Country (2017-2028) 76
10.3.2 Middle East and Africa Hepatitis A Vaccine Revenue by Country (2017-2028) 77
10.3.3 Middle East 78
10.3.4 Africa 79
11 CORPORATE PROFILE 80
11.1 GSK 80
11.1.1 GSK Corporation Information 80
11.1.2 GSK Overview 80
11.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 81
11.1.4 GSK Hepatitis A Vaccine Product Introduction 81
11.2 Merck 82
11.2.1 Merck Corporation Information 82
11.2.2 Merck Overview 83
11.2.3 Merck Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 84
11.2.4 Merck Hepatitis A Vaccine Product Introduction 84
11.2.5 Merck Recent Developments 85
11.3 Sanofi 86
11.3.1 Sanofi Corporation Information 86
11.3.2 Sanofi Overview 87
11.3.3 Sanofi Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 87
11.3.4 Sanofi Hepatitis A Vaccine Product Introduction 88
11.3.5 Sanofi Recent Developments 89
11.4 Sinovac 90
11.4.1 Sinovac Corporation Information 90
11.4.2 Sinovac Overview 90
11.4.3 Sinovac Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 91
11.4.4 Sinovac Hepatitis A Vaccine Product Introduction 91
11.4.5 Sinovac Recent Developments 92
11.5 Zhejiang Pukang 92
11.5.1 Zhejiang Pukang Corporation Information 92
11.5.2 Zhejiang Pukang Overview 93
11.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 93
11.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Introduction 94
11.6 Changchun Institute of Biological 94
11.6.1 Changchun Institute of Biological Corporation Information 94
11.6.2 Changchun Institute of Biological Overview 95
11.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 96
11.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Introduction 96
11.7 KM Biologics 97
11.7.1 KM Biologics Corporation Information 97
11.7.2 KM Biologics Overview 97
11.7.3 KM Biologics Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 99
11.7.4 KM Biologics Hepatitis A Vaccine Product Introduction 99
11.7.5 KM Biologics Recent Developments 100
11.8 IMBCAMS 101
11.8.1 IMBCAMS Corporation Information 101
11.8.2 IMBCAMS Overview 101
11.8.3 IMBCAMS Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 102
11.8.4 IMBCAMS Hepatitis A Vaccine Product Introduction 102
11.9 AIM Vaccine 103
11.9.1 AIM Vaccine Corporation Information 103
11.9.2 AIM Vaccine Overview 104
11.9.3 AIM Vaccine Hepatitis A Vaccine Sales, Price, Revenue and Gross Margin (2020-2022) 105
11.9.4 AIM Vaccine Hepatitis A Vaccine Product Introduction 105
11.9.5 AIM Vaccine Recent Developments 106
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 108
12.1 Hepatitis A Vaccine Industry Chain Analysis 108
12.2 Hepatitis A Vaccine Key Raw Materials 109
12.2.1 Key Raw Materials 109
12.2.2 Raw Materials Key Suppliers 109
12.3 Hepatitis A Vaccine Production Mode & Process 111
12.4 Hepatitis A Vaccine Sales and Marketing 112
12.4.1 Hepatitis A Vaccine Sales Channels 112
12.4.2 Hepatitis A Vaccine Distributors 113
12.5 Hepatitis A Vaccine Customers 115
13 HEPATITIS A VACCINE MARKET DYNAMICS 118
13.1.1 Hepatitis A Vaccine Industry Trends 118
13.1.2 Hepatitis A Vaccine Market Drivers 118
13.1.3 Hepatitis A Vaccine Market Challenges 119
13.1.4 Hepatitis A Vaccine Market Restraints 120
14 KEY FINDINGS IN THE GLOBAL HEPATITIS A VACCINE STUDY 121
15 APPENDIX 123
15.1 Research Methodology 123
15.1.1 Methodology/Research Approach 123
15.1.2 Data Source 126
15.2 Author Details 129
15.3 Disclaimer 129